ASSESSMENT OF RESIDUAL DISEASE IN EARLY-STAGE CERVICAL CARCINOMA FOLLOWING CONIZATION BY THREE-DIMENSIONAL POWER DOPPLER ULTRASONOGRAPHY AND HUMAN PAPILLOMAVIRUS DNA ASSAY
ASSESSMENT OF RESIDUAL DISEASE IN EARLY-STAGE CERVICAL CARCINOMA FOLLOWING CONIZATION BY THREE-DIMENSIONAL POWER DOPPLER ULTRASONOGRAPHY AND HUMAN PAPILLOMAVIRUS DNA ASSAY